Table 3.
Factors associated with all‐cause mortality (log‐rank test)
| p‐Value | |
|---|---|
| GNRI < 98 | <0.001 |
| Albumin < median (4.0 g/dL) | <0.001 |
| Age > median (82.1 years) | 0.002 |
| NT‐proBNP Q4 (>3595 pg/mL) | <0.001 |
| hs‐TNT Q4 (>45.0 pg/mL) | <0.001 |
| BMI < median (26.1 kg/m2) | 0.007 |
| COPD | 0.007 |
| History of AF | <0.001 |
| Dyslipidaemia | 0.018 |
| eGFR < median (55 mL/min) | <0.001 |
| Log. ES > median (16.1%) | <0.001 |
| LVEF < 55% | <0.001 |
| PAD | <0.001 |
| PAH | 0.005 |
| MR III–IV | 0.007 |
| TR III–IV | 0.005 |
| AKIN Stage 3 | <0.001 |
| Disabling stroke | <0.001 |
| Life‐threatening bleeding | <0.001 |
| Major access complication | <0.001 |
| Myocardial infarction | 0.011 |
AF, atrial fibrillation; AKIN, Acute Kidney Injury Network; BMI, body mass index; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; GNRI, Geriatric Nutritional Risk Index; hs‐TNT, high‐sensitive troponin T; Log. ES, logistic EuroSCORE; LVEF, left ventricular ejection fraction; MR, mitral valve regurgitation; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; PAD, peripheral artery disease; PAH, pulmonary arterial hypertension; Q, quartile; Q4, upper quartile; TR, tricuspid valve regurgitation